5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 25.13▲ | 25.13▲ | 25.13▲ | 25.12▲ | 25.14▼ |
MA10 | 25.13▲ | 25.12▲ | 25.12▲ | 25.13▼ | 25.14▼ |
MA20 | 25.12▲ | 25.12▲ | 25.12▲ | 25.14▼ | 25.14▼ |
MA50 | 25.12▲ | 25.12▲ | 25.14▼ | 25.14▼ | 25.12▲ |
MA100 | 25.13▼ | 25.14▼ | 25.14▼ | 25.13▼ | 24.97▲ |
MA200 | 25.14▼ | 25.13▼ | 25.14▼ | 25.12▲ | 24.85▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | 0.002▲ | 0.003▲ | -0.003▼ | -0.003▼ |
RSI | 72.008▲ | 62.981▲ | 57.425▲ | 47.234▼ | 49.971▼ |
STOCH | 75.000 | 77.778 | 83.333▲ | 25.926 | 50.000 |
WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -66.667 | -60.000 |
CCI | 91.629 | 90.741 | 94.574 | -33.833 | -55.414 |
CDL | $IBDQ Marubozu Candlestick Pattern Detected | Set Alert |
Tuesday, October 07, 2025 08:06 AM
Eli Lilly's four-year LUCENT-3 study shows Omvoh maintained high remission rates and a consistent safety profile in ulcerative colitis patients.
|
Tuesday, October 07, 2025 03:54 AM
New data from Eli Lilly and Company (NYSE: LLY) showed Omvoh (mirikizumab-mrkz) is the first and only interleukin-23p19 (IL-23p19) to help patients with moderately to severely active ulcerative ...
|
Friday, September 12, 2025 11:09 AM
(Reuters) - Nasdaq on Friday fired an employee for social media posts related to conservative influencer Charlie Kirk's shooting, saying they were in clear violation of its policy. Kirk, an ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
10/10/25 | 25.12 | 25.13 | 25.12 | 25.13 | 414,480 |
09/10/25 | 25.12 | 25.13 | 25.12 | 25.13 | 1,151,152 |
08/10/25 | 25.12 | 25.13 | 25.11 | 25.12 | 439,540 |
07/10/25 | 25.13 | 25.13 | 25.11 | 25.12 | 714,467 |
06/10/25 | 25.12 | 25.12 | 25.11 | 25.12 | 307,795 |
03/10/25 | 25.11 | 25.12 | 25.11 | 25.12 | 518,059 |
02/10/25 | 25.10 | 25.11 | 25.10 | 25.10 | 184,916 |
01/10/25 | 25.10 | 25.11 | 25.10 | 25.10 | 2,985,899 |
30/09/25 | 25.18 | 25.19 | 25.18 | 25.19 | 474,400 |
29/09/25 | 25.17 | 25.18 | 25.17 | 25.18 | 327,500 |
|
|
||||
|
|
||||
|
|